tradingkey.logo

Bio Rad Laboratories Inc

BIO

280.850USD

-1.410-0.50%
Horarios del mercado ETCotizaciones retrasadas 15 min
7.60BCap. mercado
23.81P/E TTM

Bio Rad Laboratories Inc

280.850

-1.410-0.50%
Más Datos de Bio Rad Laboratories Inc Compañía
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Información de la empresa
Símbolo de cotizaciónBIO
Nombre de la empresaBio Rad Laboratories Inc
Fecha de salida a bolsaMar 17, 1980
Director ejecutivoMr. Norman D. Schwartz
Número de empleados7700
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 17
Dirección1000 Alfred Nobel Dr
CiudadHERCULES
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal94547
Teléfono15107247000
Sitio Webhttps://www.bio-rad.com/
Símbolo de cotizaciónBIO
Fecha de salida a bolsaMar 17, 1980
Director ejecutivoMr. Norman D. Schwartz
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
447.98K
+1.17%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+5.80%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
1.32K
+80.52%
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
896.00
+470.70%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
808.00
+61.60%
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
612.00
+414.29%
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
308.00
--
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
308.00
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Ms. Allison Schwartz
Ms. Allison Schwartz
Director
Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
447.98K
+1.17%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+5.80%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
1.32K
+80.52%
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
896.00
+470.70%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
808.00
+61.60%
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
612.00
+414.29%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
241.70M
41.29%
Europe
199.80M
34.13%
APAC
104.10M
17.78%
Other
39.80M
6.80%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: sáb., 16 de ago
Actualizado: sáb., 16 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
First Eagle Investment Management, L.L.C.
11.45%
The Vanguard Group, Inc.
8.38%
Alice N. Schwartz Revocable Trust
8.10%
BlackRock Institutional Trust Company, N.A.
7.02%
Dimensional Fund Advisors, L.P.
4.55%
Otro
60.51%
Accionistas
Accionistas
Proporción
First Eagle Investment Management, L.L.C.
11.45%
The Vanguard Group, Inc.
8.38%
Alice N. Schwartz Revocable Trust
8.10%
BlackRock Institutional Trust Company, N.A.
7.02%
Dimensional Fund Advisors, L.P.
4.55%
Otro
60.51%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
41.56%
Investment Advisor
36.74%
Individual Investor
8.25%
Corporation
8.10%
Hedge Fund
7.05%
Research Firm
1.63%
Pension Fund
1.23%
Bank and Trust
0.83%
Sovereign Wealth Fund
0.64%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
1116
24.14M
109.77%
-3.54M
2025Q1
1170
23.54M
106.01%
-2.87M
2024Q4
1159
23.02M
100.37%
-3.90M
2024Q3
1144
23.65M
103.58%
-2.77M
2024Q2
1163
23.92M
102.32%
-878.39K
2024Q1
1175
22.36M
95.71%
-2.57M
2023Q4
1205
22.70M
94.11%
-2.35M
2023Q3
1189
22.91M
95.16%
-1.86M
2023Q2
1192
23.05M
93.93%
-1.30M
2023Q1
1200
23.34M
95.18%
-1.09M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
First Eagle Investment Management, L.L.C.
2.29M
10.36%
+728.07K
+46.49%
Apr 30, 2025
The Vanguard Group, Inc.
1.90M
8.59%
-10.12K
-0.53%
Mar 31, 2025
Alice N. Schwartz Revocable Trust
1.78M
8.04%
-3.19K
-0.18%
Feb 24, 2025
BlackRock Institutional Trust Company, N.A.
1.64M
7.42%
-4.83K
-0.29%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
877.04K
3.96%
+130.92K
+17.55%
Mar 31, 2025
Schwartz (Alice N)
951.13K
4.3%
+2.20K
+0.23%
Feb 24, 2025
Veritas Asset Management LLP
913.12K
4.12%
-63.70K
-6.52%
Mar 31, 2025
Ariel Investments, LLC
724.66K
3.27%
+164.14K
+29.28%
Mar 31, 2025
EARNEST Partners, LLC
599.62K
2.71%
-18.43K
-2.98%
Mar 31, 2025
State Street Global Advisors (US)
694.52K
3.14%
+4.36K
+0.63%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de sep
Actualizado: sáb., 6 de sep
Nombre
Proporción
Gotham 1000 Value ETF
0%
Invesco Russell 1000 Equal Weight ETF
0%
WisdomTree US MidCap Fund
0%
Invesco S&P MidCap 400 QVM Multi-factor ETF
0%
SPDR S&P 500 ETF
0%
Dimensional US Core Equity 1 ETF
0%
VanEck Morningstar ESG Moat ETF
0%
SPDR Portfolio S&P 1500 Composite Stock Market ETF
0%
ROBO Global Healthcare Technology & Innovation ETF
0%
SPDR Portfolio S&P 500 Value ETF (SPYV)
0%
Ver más
Gotham 1000 Value ETF
Proporción0%
Invesco Russell 1000 Equal Weight ETF
Proporción0%
WisdomTree US MidCap Fund
Proporción0%
Invesco S&P MidCap 400 QVM Multi-factor ETF
Proporción0%
SPDR S&P 500 ETF
Proporción0%
Dimensional US Core Equity 1 ETF
Proporción0%
VanEck Morningstar ESG Moat ETF
Proporción0%
SPDR Portfolio S&P 1500 Composite Stock Market ETF
Proporción0%
ROBO Global Healthcare Technology & Innovation ETF
Proporción0%
SPDR Portfolio S&P 500 Value ETF (SPYV)
Proporción0%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI